Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Study shows COPD is not independent risk factor for lung cancer

Written by | 21 Dec 2012

Yet, researchers say lung cancer tests needed when making COPD diagnosis.

ASH 2012 Report – Novel therapeutic agents provide hope for patients with hard-to-treat blood disorders

Written by | 21 Dec 2012

Encouraging safety and efficacy data on novel and emerging therapies presented at the 54th Annual Meeting of the American Society of Haematology (ASH) signal an important step forward… read more.

ASH 2012 Report – New multiple myeloma drug shows promise in treating people with advanced disease

Written by | 21 Dec 2012

Therapy may be new option for hard-to-treat blood cancer.

ASH 2012 Report – Potential gene therapy approach to sickle cell disease highlighted at ASH

Written by | 21 Dec 2012

Proof-of-concept animal study selected as one of the best presentations at 54th American Society of Hematology Annual Meeting and Exposition.

ASH 2012 Report – New results support bendamustine-rituximab (B-R) combination as first-line treatment in patients with (iNHL) and (MCL)

Written by | 21 Dec 2012

Data demonstrate superior patient outcomes with B-R in first-line treatment of iNHL and MCL, compared with current standard of care.

Studies from 2012 Quality Care Symposium highlight findings in improving quality of cancer care

Written by | 21 Dec 2012

Five additional studies presented at the 2012 Quality Care Symposium provided insight on how oncology practices can improve the quality of care they provide.

Genomic sequencing data guides treatment of metastatic triple-negative breast cancer patients

Written by | 21 Dec 2012

Unprecedented genomic sequencing of 14 metastatic TNBC patients yields potential drug targets

CWRU School of Medicine researchers discover new molecule linked to late-stage breast cancer

Written by | 21 Dec 2012

Researchers at Case Western Reserve University School of Medicine have identified a molecule linked to more aggressive forms of breast cancer – a discovery that could point the… read more.

PRT versus IMRT toxicity in prostate cancer

Written by | 21 Dec 2012

There is no difference between proton radiotherapy (PRT) and intensity-modulated radiotherapy (IMRT) when comparing the toxicity among  patients with prostate cancer at 12 months post-treatment according to a… read more.

Denosumab lowers cell count in giant-cell tumor of the bone

Written by | 14 Dec 2012

by Bruce Sylvester – FDA Highlights – Treatment with denosumab decreases the number of tumor giant cells in patients with giant-cell tumor of the bone, and increases new… read more.

Early resection of low-grade gliomas brings better survival rate than watchful waiting

Written by | 14 Dec 2012

by Bruce Sylvester – taken from the Journal of the American Medical Association (JAMA) – Researchers comparing methods for treating low-grade gliomas have found early surgical resection produced… read more.

ASCO 2012 Report – Bendamustine with Rituximab: More than doubles PFS in certain lymphoma patients

Written by | 20 Nov 2012

by Marybeth Burke – Initial combination chemotherapy with bendamustine and rituximab more than doubled progression-free survival to nearly 6 years compared with standard R-CHOP therapy among patients with… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.